nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylscopolamine bromide—CHRM3—muscle of abdomen—breast cancer	0.00675	0.493	CbGeAlD
Methylscopolamine bromide—Tiotropium—CYP2D6—breast cancer	0.00349	0.301	CrCbGaD
Methylscopolamine bromide—Tiotropium—CYP3A4—breast cancer	0.00299	0.258	CrCbGaD
Methylscopolamine bromide—Headache—Exemestane—breast cancer	0.00262	0.00384	CcSEcCtD
Methylscopolamine bromide—Dizziness—Ixabepilone—breast cancer	0.00261	0.00382	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Idarubicin—breast cancer	0.00259	0.00381	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Tamoxifen—breast cancer	0.00259	0.0038	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Paclitaxel—breast cancer	0.00259	0.00379	CcSEcCtD
Methylscopolamine bromide—Vomiting—Ixabepilone—breast cancer	0.00251	0.00367	CcSEcCtD
Methylscopolamine bromide—Tension—Thiotepa—breast cancer	0.00249	0.00366	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Melphalan—breast cancer	0.00249	0.00365	CcSEcCtD
Methylscopolamine bromide—Nausea—Exemestane—breast cancer	0.00248	0.00364	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Goserelin—breast cancer	0.00247	0.00363	CcSEcCtD
Methylscopolamine bromide—Nervousness—Thiotepa—breast cancer	0.00247	0.00362	CcSEcCtD
Methylscopolamine bromide—Headache—Ixabepilone—breast cancer	0.00247	0.00362	CcSEcCtD
Methylscopolamine bromide—Dizziness—Anastrozole—breast cancer	0.00245	0.0036	CcSEcCtD
Methylscopolamine bromide—Dizziness—Letrozole—breast cancer	0.00245	0.0036	CcSEcCtD
Methylscopolamine bromide—Confusional state—Goserelin—breast cancer	0.00245	0.00359	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Melphalan—breast cancer	0.00243	0.00356	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Goserelin—breast cancer	0.00242	0.00356	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Thiotepa—breast cancer	0.0024	0.00351	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Goserelin—breast cancer	0.00237	0.00347	CcSEcCtD
Methylscopolamine bromide—Vomiting—Letrozole—breast cancer	0.00236	0.00346	CcSEcCtD
Methylscopolamine bromide—Vomiting—Anastrozole—breast cancer	0.00236	0.00346	CcSEcCtD
Methylscopolamine bromide—Palpitations—Vinorelbine—breast cancer	0.00235	0.00345	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Chlorambucil—breast cancer	0.00235	0.00345	CcSEcCtD
Methylscopolamine bromide—Nausea—Ixabepilone—breast cancer	0.00234	0.00343	CcSEcCtD
Methylscopolamine bromide—Dizziness—Raloxifene—breast cancer	0.00233	0.00342	CcSEcCtD
Methylscopolamine bromide—Headache—Letrozole—breast cancer	0.00232	0.00341	CcSEcCtD
Methylscopolamine bromide—Headache—Anastrozole—breast cancer	0.00232	0.00341	CcSEcCtD
Methylscopolamine bromide—Insomnia—Tamoxifen—breast cancer	0.0023	0.00337	CcSEcCtD
Methylscopolamine bromide—Urticaria—Chlorambucil—breast cancer	0.00227	0.00332	CcSEcCtD
Methylscopolamine bromide—Vomiting—Raloxifene—breast cancer	0.00224	0.00328	CcSEcCtD
Methylscopolamine bromide—Vomiting—Idarubicin—breast cancer	0.00224	0.00328	CcSEcCtD
Methylscopolamine bromide—Constipation—Vinblastine—breast cancer	0.00223	0.00328	CcSEcCtD
Methylscopolamine bromide—Headache—Idarubicin—breast cancer	0.00221	0.00324	CcSEcCtD
Methylscopolamine bromide—Headache—Raloxifene—breast cancer	0.00221	0.00324	CcSEcCtD
Methylscopolamine bromide—Nausea—Anastrozole—breast cancer	0.0022	0.00323	CcSEcCtD
Methylscopolamine bromide—Nausea—Letrozole—breast cancer	0.0022	0.00323	CcSEcCtD
Methylscopolamine bromide—Insomnia—Goserelin—breast cancer	0.00219	0.00322	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Vinorelbine—breast cancer	0.00217	0.00319	CcSEcCtD
Methylscopolamine bromide—Constipation—Tamoxifen—breast cancer	0.00217	0.00318	CcSEcCtD
Methylscopolamine bromide—Somnolence—Goserelin—breast cancer	0.00216	0.00316	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Vinblastine—breast cancer	0.00215	0.00316	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Capecitabine—breast cancer	0.00212	0.00311	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Vinorelbine—breast cancer	0.00212	0.00311	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Chlorambucil—breast cancer	0.0021	0.00308	CcSEcCtD
Methylscopolamine bromide—Nausea—Raloxifene—breast cancer	0.00209	0.00307	CcSEcCtD
Methylscopolamine bromide—Nausea—Idarubicin—breast cancer	0.00209	0.00307	CcSEcCtD
Methylscopolamine bromide—Confusional state—Thiotepa—breast cancer	0.00209	0.00307	CcSEcCtD
Methylscopolamine bromide—Constipation—Goserelin—breast cancer	0.00207	0.00304	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Mitoxantrone—breast cancer	0.00207	0.00303	CcSEcCtD
Methylscopolamine bromide—Asthenia—Chlorambucil—breast cancer	0.00205	0.003	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Thiotepa—breast cancer	0.00202	0.00297	CcSEcCtD
Methylscopolamine bromide—Urticaria—Tamoxifen—breast cancer	0.00202	0.00296	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Goserelin—breast cancer	0.002	0.00293	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Fluorouracil—breast cancer	0.00198	0.00291	CcSEcCtD
Methylscopolamine bromide—Urticaria—Melphalan—breast cancer	0.00197	0.0029	CcSEcCtD
Methylscopolamine bromide—Urticaria—Goserelin—breast cancer	0.00193	0.00283	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Vinblastine—breast cancer	0.00193	0.00282	CcSEcCtD
Methylscopolamine bromide—Asthenia—Vinblastine—breast cancer	0.00188	0.00275	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Tamoxifen—breast cancer	0.00187	0.00274	CcSEcCtD
Methylscopolamine bromide—Constipation—Vinorelbine—breast cancer	0.00186	0.00272	CcSEcCtD
Methylscopolamine bromide—Somnolence—Thiotepa—breast cancer	0.00184	0.0027	CcSEcCtD
Methylscopolamine bromide—Ipratropium bromide—CYP2D6—breast cancer	0.00183	0.158	CrCbGaD
Methylscopolamine bromide—Hypersensitivity—Melphalan—breast cancer	0.00183	0.00269	CcSEcCtD
Methylscopolamine bromide—Asthenia—Tamoxifen—breast cancer	0.00182	0.00267	CcSEcCtD
Methylscopolamine bromide—Vomiting—Chlorambucil—breast cancer	0.00181	0.00266	CcSEcCtD
Methylscopolamine bromide—Confusional state—Irinotecan—breast cancer	0.00181	0.00265	CcSEcCtD
Methylscopolamine bromide—Confusional state—Mitoxantrone—breast cancer	0.00181	0.00265	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Irinotecan—breast cancer	0.00179	0.00263	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Mitoxantrone—breast cancer	0.00179	0.00263	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Vinorelbine—breast cancer	0.00179	0.00263	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Goserelin—breast cancer	0.00179	0.00262	CcSEcCtD
Methylscopolamine bromide—Asthenia—Melphalan—breast cancer	0.00178	0.00262	CcSEcCtD
Methylscopolamine bromide—Constipation—Thiotepa—breast cancer	0.00177	0.0026	CcSEcCtD
Methylscopolamine bromide—Tension—Paclitaxel—breast cancer	0.00176	0.00258	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Mitoxantrone—breast cancer	0.00175	0.00256	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Gemcitabine—breast cancer	0.00174	0.00256	CcSEcCtD
Methylscopolamine bromide—Asthenia—Goserelin—breast cancer	0.00174	0.00255	CcSEcCtD
Methylscopolamine bromide—Nervousness—Paclitaxel—breast cancer	0.00174	0.00255	CcSEcCtD
Methylscopolamine bromide—Confusional state—Fluorouracil—breast cancer	0.00173	0.00254	CcSEcCtD
Methylscopolamine bromide—Dizziness—Vinblastine—breast cancer	0.00173	0.00253	CcSEcCtD
Methylscopolamine bromide—Urticaria—Vinorelbine—breast cancer	0.00173	0.00253	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Fluorouracil—breast cancer	0.00172	0.00252	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Thiotepa—breast cancer	0.00171	0.00251	CcSEcCtD
Methylscopolamine bromide—Scopolamine—ABCB1—breast cancer	0.00169	0.146	CrCbGaD
Methylscopolamine bromide—Nausea—Chlorambucil—breast cancer	0.00169	0.00248	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Paclitaxel—breast cancer	0.00169	0.00247	CcSEcCtD
Methylscopolamine bromide—Dizziness—Tamoxifen—breast cancer	0.00168	0.00246	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Fluorouracil—breast cancer	0.00167	0.00246	CcSEcCtD
Methylscopolamine bromide—Vomiting—Vinblastine—breast cancer	0.00166	0.00244	CcSEcCtD
Methylscopolamine bromide—Urticaria—Thiotepa—breast cancer	0.00165	0.00242	CcSEcCtD
Methylscopolamine bromide—Headache—Vinblastine—breast cancer	0.00164	0.0024	CcSEcCtD
Methylscopolamine bromide—Insomnia—Irinotecan—breast cancer	0.00162	0.00238	CcSEcCtD
Methylscopolamine bromide—Vomiting—Tamoxifen—breast cancer	0.00161	0.00237	CcSEcCtD
Methylscopolamine bromide—Dizziness—Goserelin—breast cancer	0.0016	0.00235	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Vinorelbine—breast cancer	0.0016	0.00235	CcSEcCtD
Methylscopolamine bromide—Somnolence—Irinotecan—breast cancer	0.00159	0.00234	CcSEcCtD
Methylscopolamine bromide—Somnolence—Mitoxantrone—breast cancer	0.00159	0.00234	CcSEcCtD
Methylscopolamine bromide—Headache—Tamoxifen—breast cancer	0.00159	0.00233	CcSEcCtD
Methylscopolamine bromide—Palpitations—Paclitaxel—breast cancer	0.00158	0.00232	CcSEcCtD
Methylscopolamine bromide—Vomiting—Melphalan—breast cancer	0.00158	0.00232	CcSEcCtD
Methylscopolamine bromide—Insomnia—Gemcitabine—breast cancer	0.00158	0.00231	CcSEcCtD
Methylscopolamine bromide—Ipratropium bromide—CYP3A4—breast cancer	0.00157	0.136	CrCbGaD
Methylscopolamine bromide—Asthenia—Vinorelbine—breast cancer	0.00156	0.00229	CcSEcCtD
Methylscopolamine bromide—Nausea—Vinblastine—breast cancer	0.00155	0.00228	CcSEcCtD
Methylscopolamine bromide—Insomnia—Fluorouracil—breast cancer	0.00155	0.00228	CcSEcCtD
Methylscopolamine bromide—Somnolence—Gemcitabine—breast cancer	0.00155	0.00228	CcSEcCtD
Methylscopolamine bromide—Vomiting—Goserelin—breast cancer	0.00154	0.00226	CcSEcCtD
Methylscopolamine bromide—Constipation—Irinotecan—breast cancer	0.00153	0.00225	CcSEcCtD
Methylscopolamine bromide—Constipation—Mitoxantrone—breast cancer	0.00153	0.00225	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Thiotepa—breast cancer	0.00153	0.00224	CcSEcCtD
Methylscopolamine bromide—Somnolence—Fluorouracil—breast cancer	0.00153	0.00224	CcSEcCtD
Methylscopolamine bromide—Headache—Goserelin—breast cancer	0.00152	0.00223	CcSEcCtD
Methylscopolamine bromide—Nausea—Tamoxifen—breast cancer	0.00151	0.00221	CcSEcCtD
Methylscopolamine bromide—Constipation—Gemcitabine—breast cancer	0.00149	0.00219	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Paclitaxel—breast cancer	0.00149	0.00219	CcSEcCtD
Methylscopolamine bromide—Asthenia—Thiotepa—breast cancer	0.00149	0.00218	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Epirubicin—breast cancer	0.00148	0.00217	CcSEcCtD
Methylscopolamine bromide—Nausea—Melphalan—breast cancer	0.00148	0.00217	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Mitoxantrone—breast cancer	0.00148	0.00217	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Irinotecan—breast cancer	0.00148	0.00217	CcSEcCtD
Methylscopolamine bromide—Confusional state—Paclitaxel—breast cancer	0.00147	0.00216	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Paclitaxel—breast cancer	0.00146	0.00214	CcSEcCtD
Methylscopolamine bromide—Erectile dysfunction—Methotrexate—breast cancer	0.00145	0.00212	CcSEcCtD
Methylscopolamine bromide—Nausea—Goserelin—breast cancer	0.00144	0.00211	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Gemcitabine—breast cancer	0.00144	0.00211	CcSEcCtD
Methylscopolamine bromide—CHRM5—epithelium—breast cancer	0.00144	0.105	CbGeAlD
Methylscopolamine bromide—Dizziness—Vinorelbine—breast cancer	0.00144	0.00211	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Paclitaxel—breast cancer	0.00143	0.00209	CcSEcCtD
Methylscopolamine bromide—Urticaria—Mitoxantrone—breast cancer	0.00142	0.00209	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Fluorouracil—breast cancer	0.00141	0.00207	CcSEcCtD
Methylscopolamine bromide—Drowsiness—Methotrexate—breast cancer	0.0014	0.00205	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Capecitabine—breast cancer	0.00138	0.00203	CcSEcCtD
Methylscopolamine bromide—Vomiting—Vinorelbine—breast cancer	0.00138	0.00203	CcSEcCtD
Methylscopolamine bromide—Dizziness—Thiotepa—breast cancer	0.00137	0.00201	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Doxorubicin—breast cancer	0.00137	0.00201	CcSEcCtD
Methylscopolamine bromide—CHRM5—skin of body—breast cancer	0.00137	0.0998	CbGeAlD
Methylscopolamine bromide—Urticaria—Fluorouracil—breast cancer	0.00136	0.002	CcSEcCtD
Methylscopolamine bromide—Headache—Vinorelbine—breast cancer	0.00136	0.002	CcSEcCtD
Methylscopolamine bromide—Palpitations—Docetaxel—breast cancer	0.00134	0.00197	CcSEcCtD
Methylscopolamine bromide—Insomnia—Paclitaxel—breast cancer	0.00132	0.00194	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Irinotecan—breast cancer	0.00132	0.00194	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Mitoxantrone—breast cancer	0.00132	0.00194	CcSEcCtD
Methylscopolamine bromide—Vomiting—Thiotepa—breast cancer	0.00132	0.00193	CcSEcCtD
Methylscopolamine bromide—Drowsiness—Epirubicin—breast cancer	0.00131	0.00192	CcSEcCtD
Methylscopolamine bromide—Headache—Thiotepa—breast cancer	0.0013	0.00191	CcSEcCtD
Methylscopolamine bromide—Somnolence—Paclitaxel—breast cancer	0.0013	0.0019	CcSEcCtD
Methylscopolamine bromide—Palpitations—Capecitabine—breast cancer	0.0013	0.0019	CcSEcCtD
Methylscopolamine bromide—Nausea—Vinorelbine—breast cancer	0.00129	0.00189	CcSEcCtD
Methylscopolamine bromide—Asthenia—Mitoxantrone—breast cancer	0.00129	0.00188	CcSEcCtD
Methylscopolamine bromide—Asthenia—Irinotecan—breast cancer	0.00129	0.00188	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Fluorouracil—breast cancer	0.00126	0.00185	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Docetaxel—breast cancer	0.00126	0.00185	CcSEcCtD
Methylscopolamine bromide—Asthenia—Gemcitabine—breast cancer	0.00125	0.00184	CcSEcCtD
Methylscopolamine bromide—Constipation—Paclitaxel—breast cancer	0.00125	0.00183	CcSEcCtD
Methylscopolamine bromide—Confusional state—Docetaxel—breast cancer	0.00125	0.00183	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Docetaxel—breast cancer	0.00124	0.00182	CcSEcCtD
Methylscopolamine bromide—Nausea—Thiotepa—breast cancer	0.00123	0.00181	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Capecitabine—breast cancer	0.00122	0.00179	CcSEcCtD
Methylscopolamine bromide—Drowsiness—Doxorubicin—breast cancer	0.00121	0.00178	CcSEcCtD
Methylscopolamine bromide—Confusional state—Capecitabine—breast cancer	0.00121	0.00177	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Docetaxel—breast cancer	0.00121	0.00177	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Paclitaxel—breast cancer	0.0012	0.00177	CcSEcCtD
Methylscopolamine bromide—Dizziness—Irinotecan—breast cancer	0.00118	0.00174	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Capecitabine—breast cancer	0.00117	0.00172	CcSEcCtD
Methylscopolamine bromide—Urticaria—Paclitaxel—breast cancer	0.00116	0.0017	CcSEcCtD
Methylscopolamine bromide—Vomiting—Mitoxantrone—breast cancer	0.00114	0.00167	CcSEcCtD
Methylscopolamine bromide—Vomiting—Irinotecan—breast cancer	0.00114	0.00167	CcSEcCtD
Methylscopolamine bromide—Dizziness—Fluorouracil—breast cancer	0.00113	0.00166	CcSEcCtD
Methylscopolamine bromide—Headache—Mitoxantrone—breast cancer	0.00112	0.00165	CcSEcCtD
Methylscopolamine bromide—Headache—Irinotecan—breast cancer	0.00112	0.00165	CcSEcCtD
Methylscopolamine bromide—Insomnia—Docetaxel—breast cancer	0.00112	0.00164	CcSEcCtD
Methylscopolamine bromide—Vomiting—Gemcitabine—breast cancer	0.00111	0.00163	CcSEcCtD
Methylscopolamine bromide—Somnolence—Docetaxel—breast cancer	0.0011	0.00161	CcSEcCtD
Methylscopolamine bromide—Headache—Gemcitabine—breast cancer	0.00109	0.0016	CcSEcCtD
Methylscopolamine bromide—Vomiting—Fluorouracil—breast cancer	0.00109	0.0016	CcSEcCtD
Methylscopolamine bromide—Insomnia—Capecitabine—breast cancer	0.00108	0.00159	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Paclitaxel—breast cancer	0.00108	0.00158	CcSEcCtD
Methylscopolamine bromide—Headache—Fluorouracil—breast cancer	0.00107	0.00158	CcSEcCtD
Methylscopolamine bromide—Nausea—Mitoxantrone—breast cancer	0.00106	0.00156	CcSEcCtD
Methylscopolamine bromide—Nausea—Irinotecan—breast cancer	0.00106	0.00156	CcSEcCtD
Methylscopolamine bromide—Constipation—Docetaxel—breast cancer	0.00106	0.00155	CcSEcCtD
Methylscopolamine bromide—Asthenia—Paclitaxel—breast cancer	0.00105	0.00154	CcSEcCtD
Methylscopolamine bromide—Nausea—Gemcitabine—breast cancer	0.00104	0.00152	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Methotrexate—breast cancer	0.00103	0.00151	CcSEcCtD
Methylscopolamine bromide—Constipation—Capecitabine—breast cancer	0.00103	0.0015	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Docetaxel—breast cancer	0.00102	0.0015	CcSEcCtD
Methylscopolamine bromide—Nausea—Fluorouracil—breast cancer	0.00102	0.00149	CcSEcCtD
Methylscopolamine bromide—Tension—Epirubicin—breast cancer	0.001	0.00147	CcSEcCtD
Methylscopolamine bromide—Nervousness—Epirubicin—breast cancer	0.000994	0.00146	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Capecitabine—breast cancer	0.000988	0.00145	CcSEcCtD
Methylscopolamine bromide—Dizziness—Paclitaxel—breast cancer	0.000966	0.00142	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Epirubicin—breast cancer	0.000964	0.00141	CcSEcCtD
Methylscopolamine bromide—Urticaria—Capecitabine—breast cancer	0.000952	0.0014	CcSEcCtD
Methylscopolamine bromide—Tension—Doxorubicin—breast cancer	0.000929	0.00136	CcSEcCtD
Methylscopolamine bromide—Vomiting—Paclitaxel—breast cancer	0.000929	0.00136	CcSEcCtD
Methylscopolamine bromide—Nervousness—Doxorubicin—breast cancer	0.00092	0.00135	CcSEcCtD
Methylscopolamine bromide—Headache—Paclitaxel—breast cancer	0.000915	0.00134	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Docetaxel—breast cancer	0.000912	0.00134	CcSEcCtD
Methylscopolamine bromide—Palpitations—Epirubicin—breast cancer	0.000904	0.00133	CcSEcCtD
Methylscopolamine bromide—Confusional state—Methotrexate—breast cancer	0.0009	0.00132	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Methotrexate—breast cancer	0.000892	0.00131	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Doxorubicin—breast cancer	0.000892	0.00131	CcSEcCtD
Methylscopolamine bromide—Asthenia—Docetaxel—breast cancer	0.000888	0.0013	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Capecitabine—breast cancer	0.000883	0.0013	CcSEcCtD
Methylscopolamine bromide—Nausea—Paclitaxel—breast cancer	0.000868	0.00127	CcSEcCtD
Methylscopolamine bromide—Asthenia—Capecitabine—breast cancer	0.00086	0.00126	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Epirubicin—breast cancer	0.000852	0.00125	CcSEcCtD
Methylscopolamine bromide—Confusional state—Epirubicin—breast cancer	0.000842	0.00124	CcSEcCtD
Methylscopolamine bromide—Palpitations—Doxorubicin—breast cancer	0.000837	0.00123	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Epirubicin—breast cancer	0.000835	0.00122	CcSEcCtD
Methylscopolamine bromide—Dizziness—Docetaxel—breast cancer	0.000819	0.0012	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Epirubicin—breast cancer	0.000815	0.0012	CcSEcCtD
Methylscopolamine bromide—Insomnia—Methotrexate—breast cancer	0.000807	0.00118	CcSEcCtD
Methylscopolamine bromide—Somnolence—Methotrexate—breast cancer	0.000793	0.00116	CcSEcCtD
Methylscopolamine bromide—Dizziness—Capecitabine—breast cancer	0.000793	0.00116	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Doxorubicin—breast cancer	0.000788	0.00116	CcSEcCtD
Methylscopolamine bromide—Vomiting—Docetaxel—breast cancer	0.000787	0.00115	CcSEcCtD
Methylscopolamine bromide—Confusional state—Doxorubicin—breast cancer	0.000779	0.00114	CcSEcCtD
Methylscopolamine bromide—Headache—Docetaxel—breast cancer	0.000776	0.00114	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Doxorubicin—breast cancer	0.000773	0.00113	CcSEcCtD
Methylscopolamine bromide—Vomiting—Capecitabine—breast cancer	0.000762	0.00112	CcSEcCtD
Methylscopolamine bromide—Insomnia—Epirubicin—breast cancer	0.000755	0.00111	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Doxorubicin—breast cancer	0.000754	0.00111	CcSEcCtD
Methylscopolamine bromide—Headache—Capecitabine—breast cancer	0.000751	0.0011	CcSEcCtD
Methylscopolamine bromide—Somnolence—Epirubicin—breast cancer	0.000742	0.00109	CcSEcCtD
Methylscopolamine bromide—Nausea—Docetaxel—breast cancer	0.000735	0.00108	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Methotrexate—breast cancer	0.000735	0.00108	CcSEcCtD
Methylscopolamine bromide—Constipation—Epirubicin—breast cancer	0.000714	0.00105	CcSEcCtD
Methylscopolamine bromide—Nausea—Capecitabine—breast cancer	0.000712	0.00104	CcSEcCtD
Methylscopolamine bromide—Urticaria—Methotrexate—breast cancer	0.000709	0.00104	CcSEcCtD
Methylscopolamine bromide—Insomnia—Doxorubicin—breast cancer	0.000699	0.00103	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Epirubicin—breast cancer	0.000688	0.00101	CcSEcCtD
Methylscopolamine bromide—Somnolence—Doxorubicin—breast cancer	0.000687	0.00101	CcSEcCtD
Methylscopolamine bromide—CHRM1—female reproductive system—breast cancer	0.000667	0.0487	CbGeAlD
Methylscopolamine bromide—Urticaria—Epirubicin—breast cancer	0.000663	0.000973	CcSEcCtD
Methylscopolamine bromide—Constipation—Doxorubicin—breast cancer	0.000661	0.000969	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Methotrexate—breast cancer	0.000658	0.000964	CcSEcCtD
Methylscopolamine bromide—CHRM3—adipose tissue—breast cancer	0.000649	0.0474	CbGeAlD
Methylscopolamine bromide—Asthenia—Methotrexate—breast cancer	0.00064	0.000939	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Doxorubicin—breast cancer	0.000637	0.000934	CcSEcCtD
Methylscopolamine bromide—CHRM2—endocrine gland—breast cancer	0.00062	0.0453	CbGeAlD
Methylscopolamine bromide—Hypersensitivity—Epirubicin—breast cancer	0.000615	0.000903	CcSEcCtD
Methylscopolamine bromide—Urticaria—Doxorubicin—breast cancer	0.000614	0.0009	CcSEcCtD
Methylscopolamine bromide—Asthenia—Epirubicin—breast cancer	0.000599	0.000879	CcSEcCtD
Methylscopolamine bromide—CHRM3—female reproductive system—breast cancer	0.000597	0.0436	CbGeAlD
Methylscopolamine bromide—Dizziness—Methotrexate—breast cancer	0.00059	0.000866	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Doxorubicin—breast cancer	0.000569	0.000835	CcSEcCtD
Methylscopolamine bromide—Vomiting—Methotrexate—breast cancer	0.000567	0.000832	CcSEcCtD
Methylscopolamine bromide—CHRM1—endocrine gland—breast cancer	0.000564	0.0412	CbGeAlD
Methylscopolamine bromide—Headache—Methotrexate—breast cancer	0.000559	0.00082	CcSEcCtD
Methylscopolamine bromide—Asthenia—Doxorubicin—breast cancer	0.000554	0.000813	CcSEcCtD
Methylscopolamine bromide—Dizziness—Epirubicin—breast cancer	0.000552	0.00081	CcSEcCtD
Methylscopolamine bromide—CHRM3—female gonad—breast cancer	0.000543	0.0396	CbGeAlD
Methylscopolamine bromide—Vomiting—Epirubicin—breast cancer	0.000531	0.000779	CcSEcCtD
Methylscopolamine bromide—Nausea—Methotrexate—breast cancer	0.00053	0.000778	CcSEcCtD
Methylscopolamine bromide—Headache—Epirubicin—breast cancer	0.000523	0.000767	CcSEcCtD
Methylscopolamine bromide—Dizziness—Doxorubicin—breast cancer	0.000511	0.00075	CcSEcCtD
Methylscopolamine bromide—CHRM3—endocrine gland—breast cancer	0.000505	0.0369	CbGeAlD
Methylscopolamine bromide—Nausea—Epirubicin—breast cancer	0.000496	0.000728	CcSEcCtD
Methylscopolamine bromide—Vomiting—Doxorubicin—breast cancer	0.000491	0.000721	CcSEcCtD
Methylscopolamine bromide—Headache—Doxorubicin—breast cancer	0.000484	0.00071	CcSEcCtD
Methylscopolamine bromide—Nausea—Doxorubicin—breast cancer	0.000459	0.000673	CcSEcCtD
Methylscopolamine bromide—CHRM5—Signaling Pathways—AKT2—breast cancer	4.83e-05	0.000165	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—E2F1—breast cancer	4.82e-05	0.000165	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—PIK3CB—breast cancer	4.82e-05	0.000164	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—H2AFX—breast cancer	4.81e-05	0.000164	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—IL2—breast cancer	4.81e-05	0.000164	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—EGFR—breast cancer	4.81e-05	0.000164	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—PIK3CB—breast cancer	4.8e-05	0.000164	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—E2F1—breast cancer	4.78e-05	0.000163	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—PIK3CB—breast cancer	4.75e-05	0.000162	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—SPP1—breast cancer	4.65e-05	0.000159	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—PIK3CD—breast cancer	4.64e-05	0.000158	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—SPP1—breast cancer	4.63e-05	0.000158	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—CXCL8—breast cancer	4.63e-05	0.000158	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—CXCL8—breast cancer	4.61e-05	0.000158	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—ERBB3—breast cancer	4.6e-05	0.000157	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—PIK3CA—breast cancer	4.59e-05	0.000157	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—FGFR2—breast cancer	4.59e-05	0.000157	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—SPP1—breast cancer	4.59e-05	0.000157	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—SERPINE1—breast cancer	4.59e-05	0.000157	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—ERBB3—breast cancer	4.58e-05	0.000156	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—FGFR2—breast cancer	4.58e-05	0.000156	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—CXCL8—breast cancer	4.57e-05	0.000156	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—ERBB3—breast cancer	4.54e-05	0.000155	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—KRAS—breast cancer	4.54e-05	0.000155	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—FGFR2—breast cancer	4.53e-05	0.000155	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PIK3CG—breast cancer	4.43e-05	0.000151	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—IL2—breast cancer	4.42e-05	0.000151	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—IL2—breast cancer	4.41e-05	0.000151	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—TERT—breast cancer	4.41e-05	0.00015	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—TERT—breast cancer	4.39e-05	0.00015	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—NOS3—breast cancer	4.38e-05	0.000149	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—IL2—breast cancer	4.37e-05	0.000149	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—TERT—breast cancer	4.35e-05	0.000149	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—FGFR1—breast cancer	4.28e-05	0.000146	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—FGFR1—breast cancer	4.27e-05	0.000146	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—FGFR1—breast cancer	4.22e-05	0.000144	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—HIF1A—breast cancer	4.22e-05	0.000144	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—HIF1A—breast cancer	4.2e-05	0.000143	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—PIK3CA—breast cancer	4.17e-05	0.000142	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—HIF1A—breast cancer	4.16e-05	0.000142	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—MDM2—breast cancer	4.15e-05	0.000142	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—RAF1—breast cancer	4.14e-05	0.000141	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—RELA—breast cancer	4.12e-05	0.000141	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—LEP—breast cancer	4.11e-05	0.00014	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—LEP—breast cancer	4.1e-05	0.00014	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—ERBB2—breast cancer	4.1e-05	0.00014	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CAV1—breast cancer	4.08e-05	0.000139	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CAV1—breast cancer	4.06e-05	0.000139	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—LEP—breast cancer	4.06e-05	0.000139	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—PIK3CB—breast cancer	4.04e-05	0.000138	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—MTOR—breast cancer	4.04e-05	0.000138	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—KDR—breast cancer	4.03e-05	0.000138	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CAV1—breast cancer	4.02e-05	0.000137	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—KDR—breast cancer	4.02e-05	0.000137	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—KDR—breast cancer	3.98e-05	0.000136	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—ESR1—breast cancer	3.93e-05	0.000134	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—ESR1—breast cancer	3.92e-05	0.000134	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PIK3CD—breast cancer	3.89e-05	0.000133	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CXCL8—breast cancer	3.88e-05	0.000133	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—FN1—breast cancer	3.88e-05	0.000132	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—ESR1—breast cancer	3.88e-05	0.000132	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—FN1—breast cancer	3.87e-05	0.000132	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—HRAS—breast cancer	3.86e-05	0.000132	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—ALB—breast cancer	3.84e-05	0.000131	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—NFKBIA—breast cancer	3.83e-05	0.000131	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—FN1—breast cancer	3.83e-05	0.000131	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—NFKBIA—breast cancer	3.82e-05	0.00013	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—NOTCH1—breast cancer	3.8e-05	0.00013	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CDKN1B—breast cancer	3.79e-05	0.000129	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—NOTCH1—breast cancer	3.79e-05	0.000129	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—NFKBIA—breast cancer	3.79e-05	0.000129	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—AKT1—breast cancer	3.75e-05	0.000128	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—NOTCH1—breast cancer	3.75e-05	0.000128	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CASP3—breast cancer	3.72e-05	0.000127	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—KIT—breast cancer	3.71e-05	0.000127	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PIK3CG—breast cancer	3.71e-05	0.000127	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—APC—breast cancer	3.71e-05	0.000127	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—IL2—breast cancer	3.71e-05	0.000127	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PIK3CG—breast cancer	3.7e-05	0.000126	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—APC—breast cancer	3.7e-05	0.000126	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—KIT—breast cancer	3.7e-05	0.000126	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—IL6—breast cancer	3.69e-05	0.000126	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—NOS3—breast cancer	3.67e-05	0.000125	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—EGF—breast cancer	3.67e-05	0.000125	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—APC—breast cancer	3.67e-05	0.000125	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PIK3CG—breast cancer	3.67e-05	0.000125	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—KIT—breast cancer	3.67e-05	0.000125	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—EGF—breast cancer	3.66e-05	0.000125	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—EGF—breast cancer	3.62e-05	0.000124	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CCND1—breast cancer	3.62e-05	0.000124	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—JUN—breast cancer	3.61e-05	0.000123	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CTNNB1—breast cancer	3.58e-05	0.000122	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—MAPK3—breast cancer	3.56e-05	0.000121	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—MAPK3—breast cancer	3.55e-05	0.000121	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—MMP9—breast cancer	3.51e-05	0.00012	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—MAPK3—breast cancer	3.51e-05	0.00012	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CDKN1A—breast cancer	3.5e-05	0.000119	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—PTEN—breast cancer	3.49e-05	0.000119	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—BRAF—breast cancer	3.49e-05	0.000119	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—BRAF—breast cancer	3.48e-05	0.000119	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—BRAF—breast cancer	3.45e-05	0.000118	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—MAPK8—breast cancer	3.42e-05	0.000117	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—AKT1—breast cancer	3.41e-05	0.000116	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—IGF1—breast cancer	3.4e-05	0.000116	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—AKT2—breast cancer	3.4e-05	0.000116	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PIK3CB—breast cancer	3.39e-05	0.000116	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—IGF1—breast cancer	3.39e-05	0.000116	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—AKT2—breast cancer	3.39e-05	0.000116	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—EGFR—breast cancer	3.38e-05	0.000115	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—EGFR—breast cancer	3.37e-05	0.000115	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PTGS2—breast cancer	3.36e-05	0.000115	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—IGF1—breast cancer	3.36e-05	0.000115	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—AKT2—breast cancer	3.35e-05	0.000114	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—EGFR—breast cancer	3.34e-05	0.000114	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PIK3CD—breast cancer	3.26e-05	0.000111	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PIK3CD—breast cancer	3.25e-05	0.000111	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—SRC—breast cancer	3.24e-05	0.000111	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—PIK3CA—breast cancer	3.23e-05	0.00011	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—SERPINE1—breast cancer	3.23e-05	0.00011	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—PIK3CA—breast cancer	3.22e-05	0.00011	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PIK3CD—breast cancer	3.22e-05	0.00011	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—SERPINE1—breast cancer	3.22e-05	0.00011	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—KRAS—breast cancer	3.2e-05	0.000109	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—PIK3CA—breast cancer	3.19e-05	0.000109	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—SERPINE1—breast cancer	3.19e-05	0.000109	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—KRAS—breast cancer	3.19e-05	0.000109	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—KRAS—breast cancer	3.16e-05	0.000108	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—VEGFA—breast cancer	3.15e-05	0.000108	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—STAT3—breast cancer	3.12e-05	0.000107	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—NOS3—breast cancer	3.08e-05	0.000105	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—NOS3—breast cancer	3.07e-05	0.000105	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—NOS3—breast cancer	3.04e-05	0.000104	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—MAPK3—breast cancer	2.98e-05	0.000102	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—PIK3CA—breast cancer	2.94e-05	0.0001	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PTEN—breast cancer	2.93e-05	0.0001	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—PIK3CA—breast cancer	2.93e-05	9.99e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MDM2—breast cancer	2.92e-05	9.98e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MDM2—breast cancer	2.92e-05	9.95e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—RAF1—breast cancer	2.91e-05	9.95e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—RAF1—breast cancer	2.91e-05	9.92e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—MYC—breast cancer	2.9e-05	9.91e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—RELA—breast cancer	2.9e-05	9.91e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—PIK3CA—breast cancer	2.9e-05	9.9e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—TGFB1—breast cancer	2.9e-05	9.88e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—RELA—breast cancer	2.89e-05	9.87e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MDM2—breast cancer	2.89e-05	9.86e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—ERBB2—breast cancer	2.88e-05	9.84e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—RAF1—breast cancer	2.88e-05	9.82e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—ERBB2—breast cancer	2.87e-05	9.81e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—RELA—breast cancer	2.86e-05	9.78e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—ERBB2—breast cancer	2.85e-05	9.72e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MTOR—breast cancer	2.85e-05	9.71e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PIK3CB—breast cancer	2.85e-05	9.71e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—EGFR—breast cancer	2.84e-05	9.69e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PIK3CB—breast cancer	2.84e-05	9.68e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MTOR—breast cancer	2.84e-05	9.68e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PIK3CB—breast cancer	2.81e-05	9.59e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MTOR—breast cancer	2.81e-05	9.59e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CXCL8—breast cancer	2.73e-05	9.33e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CXCL8—breast cancer	2.73e-05	9.31e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—HRAS—breast cancer	2.72e-05	9.27e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—HRAS—breast cancer	2.71e-05	9.24e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CXCL8—breast cancer	2.7e-05	9.21e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—HRAS—breast cancer	2.68e-05	9.15e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—KRAS—breast cancer	2.68e-05	9.15e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CDKN1B—breast cancer	2.67e-05	9.12e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CDKN1B—breast cancer	2.66e-05	9.09e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—AKT1—breast cancer	2.64e-05	9.02e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CDKN1B—breast cancer	2.64e-05	9e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—AKT1—breast cancer	2.63e-05	8.99e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CASP3—breast cancer	2.62e-05	8.93e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—IL2—breast cancer	2.61e-05	8.92e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CASP3—breast cancer	2.61e-05	8.91e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—AKT1—breast cancer	2.61e-05	8.9e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—IL2—breast cancer	2.6e-05	8.89e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—IL6—breast cancer	2.6e-05	8.88e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—IL6—breast cancer	2.59e-05	8.85e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CASP3—breast cancer	2.58e-05	8.82e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—IL2—breast cancer	2.58e-05	8.81e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—IL6—breast cancer	2.57e-05	8.76e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CCND1—breast cancer	2.55e-05	8.7e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—JUN—breast cancer	2.54e-05	8.68e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CCND1—breast cancer	2.54e-05	8.67e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—JUN—breast cancer	2.53e-05	8.65e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CTNNB1—breast cancer	2.52e-05	8.61e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CCND1—breast cancer	2.51e-05	8.58e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CTNNB1—breast cancer	2.51e-05	8.58e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—JUN—breast cancer	2.51e-05	8.57e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CTNNB1—breast cancer	2.49e-05	8.5e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MMP9—breast cancer	2.47e-05	8.44e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MMP9—breast cancer	2.47e-05	8.42e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CDKN1A—breast cancer	2.46e-05	8.41e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—PIK3CA—breast cancer	2.46e-05	8.41e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PTEN—breast cancer	2.46e-05	8.39e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CDKN1A—breast cancer	2.46e-05	8.39e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PTEN—breast cancer	2.45e-05	8.37e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MMP9—breast cancer	2.44e-05	8.33e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CDKN1A—breast cancer	2.43e-05	8.3e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PTEN—breast cancer	2.43e-05	8.29e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MAPK8—breast cancer	2.41e-05	8.21e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—AKT1—breast cancer	2.4e-05	8.19e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MAPK8—breast cancer	2.4e-05	8.19e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—AKT1—breast cancer	2.39e-05	8.16e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—TP53—breast cancer	2.38e-05	8.14e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MAPK8—breast cancer	2.37e-05	8.11e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—AKT1—breast cancer	2.37e-05	8.08e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—SRC—breast cancer	2.28e-05	7.78e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—HRAS—breast cancer	2.28e-05	7.78e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—SRC—breast cancer	2.27e-05	7.76e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—SRC—breast cancer	2.25e-05	7.68e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—VEGFA—breast cancer	2.22e-05	7.58e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—VEGFA—breast cancer	2.21e-05	7.56e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—STAT3—breast cancer	2.2e-05	7.51e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—VEGFA—breast cancer	2.19e-05	7.48e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—STAT3—breast cancer	2.19e-05	7.48e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—IL6—breast cancer	2.18e-05	7.45e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—STAT3—breast cancer	2.17e-05	7.41e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MAPK3—breast cancer	2.1e-05	7.17e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MAPK3—breast cancer	2.09e-05	7.15e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MAPK3—breast cancer	2.07e-05	7.08e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PIK3CA—breast cancer	2.07e-05	7.06e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MYC—breast cancer	2.04e-05	6.98e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—TGFB1—breast cancer	2.04e-05	6.96e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MYC—breast cancer	2.04e-05	6.95e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—TGFB1—breast cancer	2.03e-05	6.94e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MYC—breast cancer	2.02e-05	6.89e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—AKT1—breast cancer	2.01e-05	6.87e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—TGFB1—breast cancer	2.01e-05	6.87e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—EGFR—breast cancer	2e-05	6.82e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—EGFR—breast cancer	1.99e-05	6.8e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—EGFR—breast cancer	1.97e-05	6.74e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—KRAS—breast cancer	1.89e-05	6.45e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—KRAS—breast cancer	1.88e-05	6.42e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—KRAS—breast cancer	1.86e-05	6.36e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PIK3CA—breast cancer	1.73e-05	5.92e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PIK3CA—breast cancer	1.73e-05	5.9e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PIK3CA—breast cancer	1.71e-05	5.85e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—AKT1—breast cancer	1.69e-05	5.77e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—TP53—breast cancer	1.68e-05	5.73e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—TP53—breast cancer	1.67e-05	5.71e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—TP53—breast cancer	1.66e-05	5.65e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—HRAS—breast cancer	1.6e-05	5.48e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—HRAS—breast cancer	1.6e-05	5.46e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—HRAS—breast cancer	1.58e-05	5.41e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—IL6—breast cancer	1.54e-05	5.24e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—IL6—breast cancer	1.53e-05	5.23e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—IL6—breast cancer	1.52e-05	5.18e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—AKT1—breast cancer	1.42e-05	4.84e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—AKT1—breast cancer	1.41e-05	4.82e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—AKT1—breast cancer	1.4e-05	4.78e-05	CbGpPWpGaD
